Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,827 | 419 | 81.2% |
| Travel and Lodging | $1,409 | 8 | 13.0% |
| Education | $326.59 | 9 | 3.0% |
| Gift | $311.36 | 4 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,527 | 113 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,183 | 68 | $0 (2024) |
| Janssen Biotech, Inc. | $1,062 | 62 | $0 (2024) |
| Olympus Corporation of the Americas | $807.81 | 7 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $706.82 | 29 | $0 (2024) |
| Wilson Cook Medical Incorporated | $608.54 | 2 | $0 (2018) |
| Celgene Corporation | $534.68 | 48 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $514.99 | 7 | $0 (2023) |
| Braintree Laboratories, Inc. | $498.06 | 11 | $0 (2023) |
| QOL Medical, LLC | $413.54 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $811.71 | 33 | ABBVIE INC. ($197.41) |
| 2023 | $2,228 | 104 | ABBVIE INC. ($562.79) |
| 2022 | $2,134 | 119 | ABBVIE INC. ($542.33) |
| 2021 | $1,962 | 120 | AbbVie Inc. ($627.35) |
| 2020 | $547.19 | 24 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($155.91) |
| 2019 | $582.45 | 12 | Covidien LP ($141.09) |
| 2018 | $1,898 | 20 | Wilson Cook Medical Incorporated ($608.54) |
| 2017 | $710.91 | 8 | Olympus Corporation of the Americas ($389.50) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/14/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Gastroenterology | ||||||
| 05/09/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: Immunology | ||||||
| 05/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Gastroenterology | ||||||
| 04/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/22/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $41.15 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/17/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: IMMUNOLOGY | ||||||
| 04/08/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: Immunology | ||||||
| 04/08/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $14.65 | General |
| Category: Gastroenterology | ||||||
| 03/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: Immunology | ||||||
| 02/27/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Immunology | ||||||
| 02/23/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Genetic Disease | ||||||
| 02/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/20/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 02/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: IMMUNOLOGY | ||||||
| 02/07/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $33.48 | General |
| Category: THERAPY FOR CSID | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 706 | 776 | $246,500 | $90,817 |
| 2022 | 15 | 683 | 772 | $275,450 | $99,460 |
| 2021 | 13 | 623 | 672 | $244,755 | $77,273 |
| 2020 | 2 | 37 | 37 | $4,695 | $2,801 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 76 | 76 | $41,800 | $15,960 | 38.2% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 28 | 61 | $25,620 | $13,192 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 140 | $37,800 | $12,979 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $34,300 | $12,303 | 35.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 112 | 112 | $26,880 | $9,296 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 80 | $9,600 | $5,250 | 54.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 47 | 47 | $21,150 | $4,960 | 23.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 26 | 26 | $10,400 | $4,768 | 45.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 23 | 23 | $11,500 | $4,210 | 36.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 50 | $15,000 | $4,163 | 27.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 51 | 51 | $7,650 | $2,296 | 30.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $4,800 | $1,440 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 127 | 127 | $44,450 | $15,809 | 35.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 65 | 65 | $36,450 | $13,772 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 136 | $36,720 | $13,706 | 37.3% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 30 | 60 | $28,000 | $13,319 | 47.6% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 12 | 13 | $26,000 | $8,629 | 33.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 43 | 43 | $17,200 | $7,434 | 43.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 80 | 80 | $19,200 | $5,975 | 31.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 26 | 26 | $13,000 | $4,642 | 35.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 46 | 47 | $15,500 | $4,024 | 26.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 35 | 35 | $16,650 | $3,553 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 48 | $5,760 | $3,002 | 52.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $5,100 | $1,775 | 34.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 34 | 34 | $5,100 | $1,770 | 34.7% |
About Rufaat Mando
Rufaat Mando is a Internal Medicine healthcare provider based in Alexandria, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2014. The National Provider Identifier (NPI) number assigned to this provider is 1205242591.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rufaat Mando has received a total of $10,874 in payments from pharmaceutical and medical device companies, with $811.71 received in 2024. These payments were reported across 440 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($8,827).
As a Medicare-enrolled provider, Mando has provided services to 2,049 Medicare beneficiaries, totaling 2,257 services with total Medicare billing of $270,351. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Alexandria, VA
- Active Since 07/07/2014
- Last Updated 08/09/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205242591
Products in Payments
- ZEPOSIA (Drug) $1,030
- XIFAXAN (Drug) $887.56
- Endocuff Devices (Device) $807.81
- STELARA (Biological) $712.73
- COOK MEDICAL ENDOSCOPIC ULTRASOUND (Device) $622.99
- ENTYVIO (Biological) $529.04
- SUTAB (Drug) $498.06
- HUMIRA (Biological) $464.39
- RINVOQ (Biological) $393.65
- MAVYRET (Drug) $387.76
- SKYRIZI (Biological) $314.70
- TRULANCE (Drug) $288.14
- SUCRAID (Drug) $281.26
- REMICADE (Biological) $249.79
- VIBERZI (Drug) $243.95
- Linzess (Drug) $239.79
- Mavyret (Drug) $232.01
- LINZESS (Drug) $208.29
- COOK MEDICAL HEMOSPRAY (Device) $186.30
- Entyvio (Biological) $177.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Alexandria
Dr. Benjamin Close, M.d, M.D
Internal Medicine — Payments: $493,843
Dr. Kanna Posina, M.d, M.D
Internal Medicine — Payments: $33,667
Robert Freedman, M.d, M.D
Internal Medicine — Payments: $18,837
Wayne Wu, M.d, M.D
Internal Medicine — Payments: $18,212
Michael Mitchell, M.d, M.D
Internal Medicine — Payments: $16,622
Scott Whittaker, M.d, M.D
Internal Medicine — Payments: $16,235